Levodopa modulates semantic fluency and uniqueness in non‐demented patients with progressive supranuclear palsy

Abstract

Abstract Introduction Semantic fluency is the ability to name items from a given category within a limited time, which relies on semantic knowledge, working memory, and executive function. Similar to patients with Parkinson's disease (PD), patients with progressive supranuclear palsy (PSP) scored lower than healthy adults in the well‐established semantic fluency test. However, it is unclear how unique are the produced words. This study examined the relationship between semantic fluency and words’ uniqueness in patients with PSP. Methods Twenty‐seven patients with PSP Richardson's syndrome (PSP‐RS), 37 patients with PD, and 41 healthy controls (HC) performed a standard semantic fluency test (animals), and their verbal responses were audio‐recorded. We used the uniqueness to reflect the ability to produce both original and effective work, that is, creativity. Results The PSP‐RS group produced fewer correct words and fewer unique words than the PD and HC groups. Moreover, the correlation between fluency and uniqueness was positive in the HC and PD groups but negative in the PSP‐RS group. Importantly, the actual levodopa dose was positively correlated with the fluency but negatively correlated with the uniqueness in PSP‐RS. The PSP‐RS patients who took a greater dose of levodopa tended to produce more correct words but fewer unique words. Conclusions These results suggested that levodopa may modulate semantic fluency and uniqueness in the early stages of PSP‐RS.

Keywords

• cognitive impairment
• levodopa
• progressive supranuclear palsy‐Richardson's syndrome
• semantic fluency
• uniqueness